POWERED BY

ZEISS expands ophthalmic portfolio

PublishedSeptember 4, 2026

ZEISS Medical Technology, one of the world’s leading medical technology companies, has announced it will showcase its latest portfolio advancements and workflow enhancements for cataract, corneal refractive, and retina, from diagnostics and surgical planning tools to new optics solutions, at the European Society of Cataract and Refractive Surgeons (ESCRS) congress in London, from September 11-14.

ZEISS will highlight its latest IOL offering at ESCRS, designed to treat cataracts while simultaneously correcting astigmatism, with a celebration in the ZEISS booth C.100 on Saturday, Sept. 12, from 10:00 – 11:00 AM BST.

At ZEISS, we’re laser focused on addressing our customers’ most pressing challenges. This year at ESCRS, we’ve expanded our ophthalmic workflows with several new clinical and surgical offerings, helping to empower clinicians with advanced optical and visualization technology and supporting more efficient, data-driven care

Andreas Völker, Head of the Ophthalmology Strategic Business Unit, ZEISS Medical Technology.

The event will include first-hand insights from surgeons who were among the first worldwide to implant the new ZEISS AT LUCIA toric 721P IOL, the world’s first hydrophobic monofocal IOL with a patented non-constant asphericity profile design (ZEISS Optic). ZEISS will also honor several surgeons with a “Pioneer Award” for their successful first implantations of the IOL.

ZEISS recently announced the EVA NEXUS ophthalmic surgical system from ZEISS in a cataract-only configuration and will showcase the new solution as part of the ZEISS Cataract Workflow.

Designed for cataract surgeons, the DORC EVA NEXUS cataract configuration now comes with a cataract grade selection feature with up to four programmable pre-sets allowing surgeons to select optimized phaco, aspiration, and irrigation settings for a more tailored approach to each surgical step and cataract grade with seamless activation via footswitch or screen. The solution also aims to support integration within the ZEISS Cataract Workflow.

Leveraging ZEISS’ long-standing experience in digital planning and building on more than 3 million cases planned in the U.S. alone using VERACITY Surgery Planner, ZEISS will highlight the newly available ZEISS Surgery Planner, a cloud-based digital planner for cataract surgery.

ZEISS Surgery Planner, in combination with ZEISS Data Analyzer, provides clinical staff with more advanced analytics. By connecting the clinical practice’s electronic medical records (EMR) to the operating room (OR), and facilitating IOL calculations as well as staff collaboration through a seamless interface, the digital planner helps clinics be more data-driven, cost-efficient, and minimizes the risk of transcription and manual input errors in comparison with a manual workflow.

ZEISS Surgery Planner will be available in Fall 2026 in select markets, including Australia, Brazil, Germany and Spain.

“With ZEISS Surgery Planner, we are advancing cataract surgery planning from manual coordination to a connected, cloud-based and data-driven workflow, helping practices reduce complexity while giving surgeons more time to focus on patient care. This technology has been proven already for many years in the U.S., with more than 3 million cases planned on VERACITY Surgery Planner, and now we are very proud to bring its success to the global stage,” says Frank Seitzinger, Head of Business Sector Surgery Anterior Segment, ZEISS Medical Technology.

At ESCRS, ZEISS will also host its Cataract Surgery Symposium on Sunday, Sept. 13, from 1:00 – 2:00 PM BST. The event will highlight “Converting astigmatism complexity into predictable outcomes with digital cataract surgery” and feature key insights from some of the industry’s leading surgeons.

Source

Discover more from NXTin health

Subscribe now to keep reading and get access to the full archive.

Continue reading